Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations Article Swipe

PDF

Federico Cappuzzo , Aditi Qamra , Eloisa Fuentes , Jennifer M. Giltnane ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1038/s41467-025-66803-8

Related Topics

Basal-Cell Carcinoma

Tom Clancy's Splinter Cell

Iron Lung (Video Game)

Concepts

No concepts available.

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1038/s41467-025-66803-8
PDF: https://www.nature.com/articles/s41467-025-66803-8_reference.pdf
OA Status: gold
References: 32
OpenAlex ID: https://openalex.org/W4416933958

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4416933958

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1038/s41467-025-66803-8

Digital Object Identifier
Title: Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-12-03

Full publication date if available
Authors: Federico Cappuzzo, Aditi Qamra, Eloisa Fuentes, Jennifer M. Giltnane

List of authors in order
Landing page: https://doi.org/10.1038/s41467-025-66803-8

Publisher landing page
PDF URL: https://www.nature.com/articles/s41467-025-66803-8_reference.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://www.nature.com/articles/s41467-025-66803-8_reference.pdf

Direct OA link when available
Cited by: 0

Total citation count in OpenAlex
References (count): 32

Number of works referenced by this work

Full payload

id	https://openalex.org/W4416933958
doi	https://doi.org/10.1038/s41467-025-66803-8
ids.doi	https://doi.org/10.1038/s41467-025-66803-8
ids.openalex	https://openalex.org/W4416933958
fwci
type	article
title	Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
is_xpac	False
apc_list.value	3920
apc_list.currency	GBP
apc_list.value_usd	4808
apc_paid.value	3920
apc_paid.currency	GBP
apc_paid.value_usd	4808
language	en
locations[0].id	doi:10.1038/s41467-025-66803-8
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S64187185
locations[0].source.issn	2041-1723
locations[0].source.type	journal
locations[0].source.is_oa	True
locations[0].source.issn_l	2041-1723
locations[0].source.is_core	True
locations[0].source.is_in_doaj	True
locations[0].source.display_name	Nature Communications
locations[0].source.host_organization	https://openalex.org/P4310319908
locations[0].source.host_organization_name	Nature Portfolio
locations[0].source.host_organization_lineage	https://openalex.org/P4310319908, https://openalex.org/P4310319965
locations[0].source.host_organization_lineage_names	Nature Portfolio, Springer Nature
locations[0].license	cc-by-nc-nd
locations[0].pdf_url	https://www.nature.com/articles/s41467-025-66803-8_reference.pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-nc-nd
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Nature Communications
locations[0].landing_page_url	https://doi.org/10.1038/s41467-025-66803-8
indexed_in	crossref, doaj
authorships[0].author.id	https://openalex.org/A5001928949
authorships[0].author.orcid	https://orcid.org/0000-0002-6295-6767
authorships[0].author.display_name	Federico Cappuzzo
authorships[0].author_position	middle
authorships[0].raw_author_name	Federico Cappuzzo
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5008643917
authorships[1].author.orcid	https://orcid.org/0000-0003-2977-0087
authorships[1].author.display_name	Aditi Qamra
authorships[1].author_position	middle
authorships[1].raw_author_name	Aditi Qamra
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5033129258
authorships[2].author.orcid
authorships[2].author.display_name	Eloisa Fuentes
authorships[2].author_position	middle
authorships[2].raw_author_name	Eloisa Fuentes
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5061348674
authorships[3].author.orcid	https://orcid.org/0000-0002-8333-9995
authorships[3].author.display_name	Jennifer M. Giltnane
authorships[3].author_position	middle
authorships[3].raw_author_name	Jennifer M. Giltnane
authorships[3].is_corresponding	False
has_content.pdf	True
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://www.nature.com/articles/s41467-025-66803-8_reference.pdf
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-12-03T00:00:00
display_name	Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations
has_fulltext	False
is_retracted	False
updated_date	2025-12-03T23:12:59.920255
primary_topic
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1038/s41467-025-66803-8
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S64187185
best_oa_location.source.issn	2041-1723
best_oa_location.source.type	journal
best_oa_location.source.is_oa	True
best_oa_location.source.issn_l	2041-1723
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	True
best_oa_location.source.display_name	Nature Communications
best_oa_location.source.host_organization	https://openalex.org/P4310319908
best_oa_location.source.host_organization_name	Nature Portfolio
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310319908, https://openalex.org/P4310319965
best_oa_location.source.host_organization_lineage_names	Nature Portfolio, Springer Nature
best_oa_location.license	cc-by-nc-nd
best_oa_location.pdf_url	https://www.nature.com/articles/s41467-025-66803-8_reference.pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-nc-nd
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Nature Communications
best_oa_location.landing_page_url	https://doi.org/10.1038/s41467-025-66803-8
primary_location.id	doi:10.1038/s41467-025-66803-8
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S64187185
primary_location.source.issn	2041-1723
primary_location.source.type	journal
primary_location.source.is_oa	True
primary_location.source.issn_l	2041-1723
primary_location.source.is_core	True
primary_location.source.is_in_doaj	True
primary_location.source.display_name	Nature Communications
primary_location.source.host_organization	https://openalex.org/P4310319908
primary_location.source.host_organization_name	Nature Portfolio
primary_location.source.host_organization_lineage	https://openalex.org/P4310319908, https://openalex.org/P4310319965
primary_location.source.host_organization_lineage_names	Nature Portfolio, Springer Nature
primary_location.license	cc-by-nc-nd
primary_location.pdf_url	https://www.nature.com/articles/s41467-025-66803-8_reference.pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-nc-nd
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Nature Communications
primary_location.landing_page_url	https://doi.org/10.1038/s41467-025-66803-8
publication_date	2025-12-03
publication_year	2025
referenced_works	https://openalex.org/W4234236664, https://openalex.org/W4205923470, https://openalex.org/W2122495232, https://openalex.org/W2790574591, https://openalex.org/W3091399767, https://openalex.org/W3095297211, https://openalex.org/W2805354595, https://openalex.org/W3183409909, https://openalex.org/W3106818633, https://openalex.org/W2886963239, https://openalex.org/W4213441758, https://openalex.org/W4206801412, https://openalex.org/W4309183981, https://openalex.org/W2180481128, https://openalex.org/W4293574844, https://openalex.org/W4378953806, https://openalex.org/W3161537813, https://openalex.org/W4226316837, https://openalex.org/W3025022288, https://openalex.org/W2804812017, https://openalex.org/W4284964011, https://openalex.org/W3160770363, https://openalex.org/W4391848181, https://openalex.org/W2785803176, https://openalex.org/W2805302875, https://openalex.org/W4283325186, https://openalex.org/W3096713247, https://openalex.org/W4316810205, https://openalex.org/W4403953218, https://openalex.org/W4319298155, https://openalex.org/W2136787567, https://openalex.org/W2038014733
referenced_works_count	32
abstract_inverted_index
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	4
citation_normalized_percentile